hospitalised patient
[용어속성] Patient
Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II)
중증 COVID-19 환자를 치료하기 위한 동종 인간 치수 줄기세포의 안전성 및 효능 평가: 무작위 대조 시험(I/II상)을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
Acidic
Adenovirus
Admission
AIDS
Alanine
alanine aminotransferase
albumin
alkaline phosphatase
Allogeneic
allogeneic human dental pulp stem cells
amyloid
Analysis
anion gap
Arm ratio
aspartate
Aspartate aminotransferase
average
B lymphocyte
basophils
Before menopause
Bilirubin
blind
blinded
Block randomization method
Blood
blood cell
Blood cells
blood pressure
Blood routine
C-reactive protein
calcium
carbon dioxide
Care
CAST
caused
Cell
cell suspension
change
chest X-ray
Child Pugh score
chlorine
cholesterol
cholinesterase
CLARITY
clinical
Clinical improvement
clinical trial
coded
Coefficient of variation
color
commenced
comparator
computer
Concentration
Consent
consent form
Continuous renal replacement therapy
control group
control groups
COVID-19
COVID-19; randomised controlled trial; protocol; human dental pulp stem cells; dental stem cell banking
COVID-2019
creatine
creatine kinase
creatinine
criteria
crystal
Cytokines
cytomegalovirus
cytomegalovirus CMV-IgG
cytomegalovirus CMV-IgM
Definition
dental pulp
dental pulp stem cells
description
detect
Diastolic blood pressure
direct bilirubin
discharge
disease
dissemination
distress
distribution
DPSCs
ECMO
Efficacy
element
enrolled
eosinophil
eosinophils
epithelial cells
estimated glomerular filtration rate
Estrogen
examined
excluded
exclusion criteria
experimental group
fat globules
Female patients
female subject
filtration rate
Final
flow cytometry
follow-up period
fungi
fungus
Globulin
glomerular filtration rate
Glucose
GRADE
Grade 1
grade 3
Grade 5
granulocyte
HBcAb
HBeAb
HBeAg
HBsAb
HBsAg
hDPSCs
Health Organization
heart rate
hematocrit
Hemodialysis
hemoglobin
hepatitis B
hepatitis C
HFNC
high density lipoprotein
hospitalised patient
Hospitalised patients
Hospitalization
Hospitalized
human DPSC
human DPSCs
hypersensitive C-reactive protein
hypoxia
Identifier
IgA
IgG
IgM
Il -10
IL-1
IL-1 β
IL-2
IL-4
IL-6
immune
Immunoglobulin
Immunological testing
improvement
IMV
inclusion criteria
Infectious disease
Influenza
Influenza virus
informed consent form
injection
Injections
intensive care
intensive care unit
Intravenous injection
Invasive mechanical ventilation
investigator
investigators
ITN-γ
ketone
ketone bodies
Kidney function
Kidney function tests
Killer cell
Laboratory
laboratory examinations
Lactate
lactate dehydrogenase
lactating women
leukocyte
leukocyte enzymes
lipoprotein
lipoprotein A
lipoprotein cholesterol
low density lipoprotein
lung lesion
lung lesions
lymphocyte
Lymphocytes
Macrophage
Magnesium
Medical care
Menopause
Monocytes
mononuclear cell
mononuclear cells
nasal
nasal catheter
natural killer
natural killer cell
neutrophil
Neutrophils
nitrite
NIV
Non-invasive
non-invasive mechanical ventilation
non-squamous epithelial cell
non-squamous epithelial cells
nucleic acid
nucleic acid test
number
objective
observation
occult
occult blood
Other
Other condition
outcome
oxygen
oxygen saturation
parallel group
parasites
partial pressure
participant
Patient
penetration
performed
Peripheral blood
Peritoneal dialysis
phase
phenotype
phosphatase
phosphorus
Placebo
placebo-controlled
Platelet
Platelet count
platelet distribution width
Platelets
Potassium
prealbumin
pregnancy test
pregnant
pressure
Primary outcome
Protein
protocol
random
randomisation
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
red blood cell
red blood cells
renal
renal insufficiency
renal replacement therapy
Renmin Hospital
replacement therapy
required
researcher
respiratory
respiratory distress
respiratory infection
respiratory rate
Safety
Saline
saline solution
Sample size
SARS-CoV-2
secondary
Secondary outcomes
serious COVID-19
serum
serum amyloid
severe liver condition
severe pneumonia
single-cell analyses
sodium
specific gravity
Standard deviation
status
stem cell
study period
Study protocol
sugar
syphilis
Systolic blood pressure
T lymphocyte
Th1 cytokine
Th1 cytokines
Th2 cytokine
Th2 cytokines
therapeutic effect
therapeutic effects
time
TNF-a
Total
total bilirubin
Total cholesterol
total protein
traits
Transferrin
treat
Treatment
treatment for COVID-19
triacylglycerol
Trial
triple blinded
TTCI
Tuberculosis
Twenty participant
Twenty participants
university
urea
uric acid
Urine
urobilinogen
Variation
Version
vital signs
Volume
website
White blood cells
with HIV
within 6 months
women
World Health Organization
Wuhan
γ-glutamyl transferase
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04380-5 PMC 바로가기 [Article Type] Letter
Factors associated with the duration of hospitalisation among COVID-19 patients in Vietnam: A survival analysis
Original Paper
[키워드] age
Analysis
applied
China
Comorbidities
conditions
Contamination
Control
country
COVID-19
COVID-19 patient
determine
died
discharged
duration of hospitalisation
duration of stay
elapsed
Factor
Factors
females
Global study
hospital
Hospital admission
Hospital stay
hospitalisation
hospitalised patient
identify
indicated
individual
life-threatening
median
multivariable Cox regression
Patient
potential risk
prevention
recorded
Regression model
reported
resource
Result
retrospective
severely ill patient
significantly
specificity
Stage
steering committee
study period
Support
survival
symptom onset
the median
the SARS-CoV-2 virus
Treatment
Vietnam
with COVID-19
[DOI] 10.1017/S0950268820001259 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.1017/S0950268820001259 PMC 바로가기 [Article Type] Original Paper
Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
7-point ordinal scale
accelerate
activities
activity
acute respiratory syndrome
adaptive
addition
administration
Admission
airway
Akershus
allocation sequence
Analysis
anticipated
approach
automatically
baseline
Biochemistry
Biomarker
blinded
Blinding
Blood
C-reactive protein
cardiac troponin
Chloroquine
clinical
Clinical outcome
Clinical practice
clinical status
clinical symptom
collected
condition
coronavirus
coronavirus disease
COVID-19
Culture
database
Department
disease
dissemination
early treatment
element
Endpoint
examined
excluded
extracorporeal membrane oxygenation
Good
harmonization
hepatic injury
history
hospital
Hospital admission
hospitalisation
hospitalised
hospitalised patient
Hospitalized
Hydroxychloroquine
Hypothesis
In-hospital
include
independent
Inpatient
intensive care
intensive care unit
International Conference
Intervention
intervention arm
Invasive mechanical ventilation
Laboratory
marker
Microbiology
Mortality
nasopharyngeal
NEWS2
non-invasive ventilation
Norway
number
Nurse
objective
open label
Oropharyngeal
Oropharyngeal sampling
outcome
oxygen
participant
Patient
patients
peptide
Placebo
polymerase chain
polymerase chain reaction
positive
Practice
Pragmatic
pragmatic trial
primary endpoint
profile
Prolonged
Protein
protocol
QT interval
randomisation
randomised
randomised controlled
randomised controlled trial
randomization
Randomized
Randomized controlled trial
recruited
recruitment
Registered
renal
requiring supplemental oxygen
resource
responsible
RT-PCR
Safe
Sample size
SARS-CoV-2
SARS-CoV-2 viral load
score
secondary
Seven
standard care
statistical analyses
status
Study protocol
subjects
Surveillance
therapy
transcriptase
Treatment
treatment allocation
Trial
Two-arm
university
use of hydroxychloroquine
Viral load
virological clearance
viruses
vital signs
website
[DOI] 10.1186/s13063-020-04420-0 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04420-0 PMC 바로가기 [Article Type] Letter
Umbilical cord blood therapy to prevent progression of COVID-19 related pneumonia: a structured summary of a study protocol for a pilot randomised controlled trial
Letter
[키워드] 1:1
24 hour
acute COVID-19
administration
Anti-inflammatory
ARDS
block
Blood
blood cell
Cell
cells
clinical
Clinical improvement
control group
Cord blood
COVID-19
COVID-19 patients
dissemination
dose
Efficacy
element
Estimated
feasibility
feasible
hospitalised patient
immunomodulatory properties
infected with SARS-CoV-2
injection
intravenous
Melbourne, Australia
moderate
New
number
objective
occur
outcome
participant
Patient
Placebo
Pneumonia
Prevent
progression
protocol
randomised
randomised controlled trial
RCT
recruit
recruitment
Registered
registry
Safety
Sample size
SARS-COV-2 infection
sealed
severe ARDS
severe pneumonia
Standard
status
stem cells
Study protocol
supportive care
therapy
Tolerability
Total
Treatment
Trial
Umbilical cord
umbilical cord blood
virus
website
[DOI] 10.1186/s13063-020-04387-y PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04387-y PMC 바로가기 [Article Type] Letter
COVID-19 and smoking: A systematic review of the evidence
Editorial
[키워드] 2019 novel coronavirus
2019-nCoV
Admission
adverse outcome
adverse outcomes
Analysis
association
assumed
autonomous
available data
calculate
Care
changes in
Characteristics
chest radiology
China
clinical
Clinical characteristics
Clinical outcome
clinical symptom
clinically
cohort study
conducted
coronavirus
Course
COVID-19
COVID-19 pandemic
current
database
death
deaths
detrimental
diagnosed
died
discharged
disease
Disease progression
English
epidemiological
evaluate
Evidence
Factor
feature
FIVE
former
Health
hospital
hospitalisation
hospitalised patient
Hospitalization
humans
ICU
ICU care
immune system
inclusion criteria
Increases
indicated
individual
infected with COVID-19
infected with SARS-CoV-2
infections
Infectious disease
Influenza
information
Inpatient
intensive care
Italy
Laboratory
laboratory-confirmed
Logistic regression
Logistic regression analysis
lung
majority
mechanical ventilation
MERS-CoV
Mortality
mortality risk factor
multicenter cohort study
multicentre
multivariate
multivariate logistic regression
negative
non-ICU
non-severe patient
non-survivor
outbreak
outcome
pandemic
Patient
patients
patients died
patients with COVID-19
percentage
plethora
Population
positive
previous study
Prognosis
Prognostic factor
progression
proportion
Prospective
provided
pulmonary
ranged
Region
regions
reported
Research
Respiratory disease
retrieved
retrospective
retrospective cohort study
risk factor
Sample size
searched
setting
Severe case
Severe patient
severe symptom
severe symptoms
severity
shown
significantly higher
small sample size
smoker
Smokers
smoking
smoking status
statistical analysis
statistically significant
statistically significant difference
Study design
study population
Support
survived
survivor
Symptom
Symptoms
systematic review
table
tested
the disease
the patient
those that survived
title
Tobacco
two group
were excluded
were used
with COVID-19
Wuhan
Wuhan, China
[DOI] 10.18332/tid/119324 PMC 바로가기 [Article Type] Editorial
[DOI] 10.18332/tid/119324 PMC 바로가기 [Article Type] Editorial
Human respiratory coronavirus HKU1 versus other coronavirus infections in Italian hospitalised patients
Article
[키워드] 229E
Acute respiratory tract infections
Analysis
ARTI, acute respiratory tract infections
BAL, bronchoalveolar lavage
caused
clinical symptom
compared
contribute
Coronavirus infection
detected
DFA, direct fluorescent antibody staining
Diagnosis
diagnostic
epidemiological
feature
found
Genotype
HCoV
HCoVs
hCoVs, human coronavirus
HKU1
HKU1 genotypes
Hong Kong
hospitalised
hospitalised patient
Human
Human coronavirus HKU1
identify
Infected
Infection
infections
Italian
Italy
longitudinal
MAbs, monoclonal antibodies
monoclonal antibody
nine
NPA, nasopharyngeal aspirate
objective
Patient
patient population
patients
performed
predominant
Prospective Study
reported
Respiratory Coronavirus
respiratory tract infection
Result
reverse transcription-PCR
rhinorrhea
RT-PCR
RT-PCR, reverse transcription-PCR
significantly lower
strain
SVC, shell-vial cultures
[DOI] 10.1016/j.jcv.2006.12.008 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.jcv.2006.12.008 PMC 바로가기 [Article Type] Article
Croup Is Associated with the Novel Coronavirus NL63
Research Article
[키워드] absence
age
analysed
association
children
Co-infection
collected
compared
coronavirus
Croup
detected
determined
different
disease
finding
fraction
Germany
HCoV-NL63
hospitalised patient
Infection
investigated
Lower respiratory tract
median
nasopharyngeal secretion
NL63
novel
occur
Outpatient
parainfluenza virus 3
Patient
positive
prevalent
Quantitative
Real-time PCR
Region
respiratory syncytial virus
respiratory virus
respiratory viruses
RNA
Sample
significantly higher
suffered
Viral load
Viral RNA
[DOI] 10.1371/journal.pmed.0020240 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.0020240 PMC 바로가기 [Article Type] Research Article